U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
163711163711Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample ProcurementCompletedNo Results AvailableAcute Coronary Syndrome (ACS)Device: Biomarkershttps://ClinicalTrials.gov/show/NCT00415948
163712163712PRINTO (the Paediatric Rheumatology International Trials Organisation)RecruitingNo Results AvailableJuvenile Idiopathic ArthritisDrug: methotrexatehttps://ClinicalTrials.gov/show/NCT00415935
163713163713Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: ELC200 (carbidopa+levodopa+entacapone)https://ClinicalTrials.gov/show/NCT00415922
163714163714TALL-104 and Gleevec in Chronic Myelogenous Leukemia PatientsTerminatedHas ResultsChronic Myelogenous LeukemiaDrug: Imatinib Mesylate (IM)|Drug: TALL-104 cellshttps://ClinicalTrials.gov/show/NCT00415909
163715163715Impact of Respiratory Muscle Unloading on Respiratory Muscle EnduranceRecruitingNo Results AvailableChronic Respiratory FailureDevice: positive pressure ventilationhttps://ClinicalTrials.gov/show/NCT00415896
163716163716To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Valsartanhttps://ClinicalTrials.gov/show/NCT00415883
163717163717mDiet - Ecological Momentary Intervention of Diet Via Mobile TechnologyCompletedHas ResultsOverweightBehavioral: Printed Material|Behavioral: Weekly Weighing|Behavioral: Cell phone will serve as a self monitoring device|Device: Text Message|Behavioral: Diet Goals via Cell Phone|Behavioral: Food Monitoringhttps://ClinicalTrials.gov/show/NCT00415870
163718163718Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R)TerminatedHas ResultsLeukemiaBiological: Peptide Vaccine (PR1 Peptide)|Drug: Peginterferon alfa-2b|Drug: Imatinib|Drug: GM-CSFhttps://ClinicalTrials.gov/show/NCT00415857
163719163719Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: ELC200 (carbidopa+levodopa+entacapone)https://ClinicalTrials.gov/show/NCT00415844
163720163720Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: ELC200 (carbidopa+levodopa+entacapone)https://ClinicalTrials.gov/show/NCT00415831
163721163721Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung CancerCompletedNo Results AvailableCarcinoma, Non-Small-Cell LungBiological: MVA-MUC1-IL2|Drug: 1st line Chemotherapyhttps://ClinicalTrials.gov/show/NCT00415818
163722163722Renal MRA Crossover Study Comparing Multihance to Another Contrast AgentCompletedNo Results AvailableSteno-Occlusive DiseaseDrug: Multihance|Drug: vasovisthttps://ClinicalTrials.gov/show/NCT00415805
163723163723Comparison Between hCG and GnRH Agonist for Ovulation Induction in Patients With High Response to IVF DrugsActive, not recruitingNo Results AvailableInfertilityDrug: Arvekap, Pregnylhttps://ClinicalTrials.gov/show/NCT00415792
163724163724ZANTE: Zometa and Taxotere in Hormone Refractory Prostate CancerCompletedNo Results AvailableMetastatic Prostate CancerDrug: docetaxel|Drug: zoledronic acidhttps://ClinicalTrials.gov/show/NCT00415779
163725163725Comparison Between Recombinant Versus Urinary hCG for Ovulation InductionActive, not recruitingNo Results AvailableInfertilityDrug: ovidrele, pregnylhttps://ClinicalTrials.gov/show/NCT00415766
163726163726Procalcitonin as a Marker of Bacterial PneumoniaCompletedNo Results AvailablePneumonia|Bronchitis|COPDBehavioral: No antibiotics if se-procalcitonin is below stated limithttps://ClinicalTrials.gov/show/NCT00415753
163727163727Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: ELC200 (carbidopa+levodopa+entacapone)https://ClinicalTrials.gov/show/NCT00415740
163728163728Prevention Of Morbidity In Sickle Cell Disease Pilot PhaseRecruitingNo Results AvailableSickle Cell AnaemiaDevice: auto Continuous Positive Airways Pressure (CPAP) with oxygen supplementationhttps://ClinicalTrials.gov/show/NCT00415727
163729163729Safety and Efficacy of an Ambulatory Biofeedback Device for Primary InsomniaRecruitingNo Results AvailablePrimary InsomniaDevice: Portable Biofeedbackhttps://ClinicalTrials.gov/show/NCT00415714
163730163730Effect of Etomidate on Hemodynamics and Adrenocortical Function After Cardiac SurgeryCompletedNo Results AvailableCoronary Artery Disease|Mitral Valve RegurgitationDrug: Etomidate|Drug: Propofol|Drug: Hydrocortisone|Drug: NaCl 0.9%|Other: Tetracosactinhttps://ClinicalTrials.gov/show/NCT00415701
163731163731Lifestyle Modification for Obesity-Related Type 2 DiabetesCompletedNo Results AvailableType 2 Diabetes Mellitus|Overweight|ObesityBehavioral: Low carbohydrate, ketogenic diet|Behavioral: Low glycemic index, reduced calorie diethttps://ClinicalTrials.gov/show/NCT00415688
163732163732Respiratory Tumor and Normal Tissue MotionCompletedNo Results AvailableLung Cancer|Abdominal CancerProcedure: Motion CT Scanshttps://ClinicalTrials.gov/show/NCT00415675
163733163733Effect of Biomagnetic Therapy on GonarthrosisTerminatedNo Results AvailableKnee OsteoarthritisDevice: Pulsed Signal Therapy (PST)https://ClinicalTrials.gov/show/NCT00415662
163734163734Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African AdultsWithdrawnNo Results AvailableHIV InfectionsBiological: VRC-HIVDNA016-00-VP|Biological: VRC-HIVADV014-00-VP|Biological: Vaccine placebohttps://ClinicalTrials.gov/show/NCT00415649
163735163735Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With CancerCompletedNo Results AvailableCancerDrug: IC83/LY2603618|Drug: pemetrexedhttps://ClinicalTrials.gov/show/NCT00415636
163736163736A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is InsufficientCompletedHas ResultsHypertensionDrug: Amlodipine|Drug: Amlodipinehttps://ClinicalTrials.gov/show/NCT00415623
163737163737Antihypertensive Treatment in Acute Cerebral HemorrhageCompletedHas ResultsIntracerebral Hemorrhage|Hypertension|StrokeDrug: nicardipinehttps://ClinicalTrials.gov/show/NCT00415610
163738163738Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant PainCompletedHas ResultsPainDrug: ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride ER)https://ClinicalTrials.gov/show/NCT00415597
163739163739Cinacalcet to Treat Hypercalcemia in Renal Transplant RecipientsWithdrawnNo Results AvailableSecondary Hyperparathyroidism|HypercalcemiaDrug: Cinacalcet HClhttps://ClinicalTrials.gov/show/NCT00415584
163740163740Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 InhibitorsCompletedNo Results AvailableHypogonadism|Erectile DysfunctionDrug: Fispemifene (once daily for 8 weeks)https://ClinicalTrials.gov/show/NCT00415571

* Görseller ve İçerik tekif hakkına sahip olabilir